Functional analyses of rare genetic variants in complement component C9 identified in patients with age-related macular degeneration

Human Molecular Genetics
Mariann KremlitzkaAnna M Blom

Abstract

Age-related macular degeneration (AMD) is a progressive disease of the central retina and the leading cause of irreversible vision loss in the western world. The involvement of abnormal complement activation in AMD has been suggested by association of variants in genes encoding complement proteins with disease development. A low-frequency variant (p.P167S) in the complement component C9 (C9) gene was recently shown to be highly associated with AMD; however, its functional outcome remains largely unexplored. In this study, we reveal five novel rare genetic variants (p.M45L, p.F62S, p.G126R, p.T170I and p.A529T) in C9 in AMD patients, and evaluate their functional effects in vitro together with the previously identified (p.R118W and p.P167S) C9 variants. Our results demonstrate that the concentration of C9 is significantly elevated in patients' sera carrying the p.M45L, p.F62S, p.P167S and p.A529T variants compared with non-carrier controls. However, no difference can be observed in soluble terminal complement complex levels between the carrier and non-carrier groups. Comparing the polymerization of the C9 variants we reveal that the p.P167S mutant spontaneously aggregates, while the other mutant proteins (except for C9 p.A529T) ...Continue Reading

References

Jan 1, 1982·Proceedings of the National Academy of Sciences of the United States of America·E R Podack, J Tschopp
Jul 4, 2008·PloS One·Hendrik P N SchollMartin Oppermann
Aug 8, 2009·Investigative Ophthalmology & Visual Science·Robyn ReynoldsJohanna M Seddon
Mar 2, 2010·BMJ : British Medical Journal·Usha ChakravarthyPhilip J Rosenfeld
Aug 11, 2010·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Jason Noble, Varun Chaudhary
Aug 20, 2010·Nature Immunology·Daniel RicklinJohn D Lambris
Jul 7, 2011·Experimental Eye Research·Robert F MullinsEdwin M Stone
Dec 23, 2011·Investigative Ophthalmology & Visual Science·Koji M NishiguchiHiroko Terasaki
Dec 19, 2012·Immunologic Research·Sonia I VlaicuHorea Rus
Jan 1, 2014·Progress in Retinal and Eye Research·Lucia Sobrin, Johanna M Seddon
May 7, 2014·Sub-cellular Biochemistry·Andreas F-P Sonnen, Philipp Henneke
Jul 31, 2014·Investigative Ophthalmology & Visual Science·Tina RistauSascha Fauser
Nov 14, 2014·PloS One·Dzenita SmailhodzicB Jeroen Klevering
Jan 16, 2016·JAMA Ophthalmology·Nicole T M SaksensAnneke I den Hollander
Feb 5, 2016·Nature Communications·Natalya V DudkinaMichelle A Dunstone
Aug 19, 2016·Nature·Monkol LekUNKNOWN Exome Aggregation Consortium

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alternative Complement Pathway

The Alternative Complement Pathway is part of the innate immune system, and activation generates membrane attack complexes that kill pathogenic cells. Discover the latest research on the Alternative Complement Pathway.